Avinger Announces Participation in Canaccord Genuity 37th Annual Growth Conference
August 03 2017 - 4:01PM
Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative
treatments for peripheral artery disease (PAD), today announced
that the Company will be participating in the Canaccord Genuity
37th Annual Growth Conference in Boston.
Avinger management is scheduled to present on Thursday, August
10, 2017 at 10:30am ET. Interested parties can access the live
audio webcast with accompanying slides from the Events section of
Avinger’s website at www.avinger.com. The webcast replay will be
available after the conclusion of the live presentation for 90
days.
About Avinger, Inc. Founded in 2007, Avinger,
Inc. is a commercial-stage medical device company that designs and
develops the first-ever image-guided, catheter-based system that
diagnoses and treats patients with peripheral arterial disease
(PAD). Avinger is dedicated to radically changing the way vascular
disease is treated through their Lumivascular platform which
currently consists of the Lightbox imaging console, the Ocelot
family of catheters designed for chronic total occlusions (CTOs),
and Pantheris designed for atherectomy. Avinger is based in
Redwood City, CA. For more information, please visit
www.avinger.com.
Investor Contact:
Matt Ferguson
Avinger, Inc.
(650) 241-7917
ir@avinger.com
Avinger (NASDAQ:AVGR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Avinger (NASDAQ:AVGR)
Historical Stock Chart
From Apr 2023 to Apr 2024